TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE

2012 ◽  
Vol 29 (7) ◽  
pp. 587-596 ◽  
Author(s):  
Linda L. Carpenter ◽  
Philip G. Janicak ◽  
Scott T. Aaronson ◽  
Terrence Boyadjis ◽  
David G. Brock ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Transcranial Magnetic Stimulation ◽  
Major Depression ◽  
Observational Study ◽  
Treatment Outcomes ◽  
Acute Treatment ◽  
Magnetic Stimulation

scholarly journals Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice

CNS Spectrums ◽  
2013 ◽  
Vol 18 (6) ◽  
pp. 322-332 ◽  
Author(s):  
Philip G. Janicak ◽  
David L. Dunner ◽  
Scott T. Aaronson ◽  
Linda L. Carpenter ◽  
Terrence A. Boyadjis ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Clinical Practice ◽  
Transcranial Magnetic Stimulation ◽  
Functional Status ◽  
Acute Treatment ◽  
Magnetic Stimulation ◽  
Persistent Symptoms ◽  
Sf 36 ◽  
Patient Reported

BackgroundTranscranial magnetic stimulation (TMS) is an effective and safe therapy for major depressive disorder (MDD). This study assessed quality of life (QOL) and functional status outcomes for depressed patients after an acute course of TMS.MethodsForty-two, U.S.-based, clinical TMS practice sites treated 307 outpatients with a primary diagnosis of MDD and persistent symptoms despite prior adequate antidepressant pharmacotherapy. Treatment parameters were based on individual clinical considerations and followed the labeled procedures for use of the approved TMS device. Patient self-reported QOL outcomes included change in the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the EuroQol 5-Dimensions (EQ-5D) ratings from baseline to end of the acute treatment phase.ResultsStatistically significant improvement in functional status on a broad range of mental health and physical health domains was observed on the SF-36 following acute TMS treatment. Similarly, statistically significant improvement in patient-reported QOL was observed on all domains of the EQ-5D and on the General Health Perception and Health Index scores. Improvement on these measures was observed across the entire range of baseline depression symptom severity.ConclusionThese data confirm that TMS is effective in the acute treatment of MDD in routine clinical practice settings. This symptom benefit is accompanied by statistically and clinically meaningful improvements in patient-reported QOL and functional status outcomes.

Ten years' data of Transcranial Magnetic Stimulation (TMS): a naturalistic, observational study outcome in clinical practice

2021 ◽  
pp. 113986
Author(s):  
Abdullah Bolu ◽  
İbrahim Gündoğmuş ◽  
Mehmet Sinan Aydın ◽  
Duygu Fadıloğlu ◽  
Yasemin Erken ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Transcranial Magnetic Stimulation ◽  
Observational Study ◽  
Magnetic Stimulation
Sign in / Sign up

Export Citation Format

Share Document